• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Can sarcopenia predict outcomes in bladder cancer patients treated with chemoradiotherapy?

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Corden, Michael
    Chin, S.
    Cree, Anthea
    Hoskin, Peter J
    McWilliam, Alan
    Satiti, A. D.
    Song, Yee Pei
    Green, Andrew
    Choudhury, Ananya
    Affiliation
    The University of Manchester, Radiotherapy Related Research, Manchester,
    Issue Date
    2020
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective Bladder cancer is the tenth commonest malignancy in the UK, with approximately 10,200 new diagnoses and 5,400 deaths annually. Sarcopenia shows promise as a prognostic factor for bladder cancer and has been shown to predict overall survival (OS) in patients treated with radical cystectomy. The present study aims to assess sarcopenia as a predictor of OS and progression-free survival (PFS) in patients with urothelial carcinoma (UC) of the bladder treated with organ-sparing concurrent gemcitabine and radiotherapy (GemX). Material and Methods 244 patients with non-metastatic UC, treated from 2010- 2017 with 52.5Gy in 20 fractions of curative intent radiotherapy with weekly gemcitabine, were identified for analysis. Pre-treatment computed tomography (CT) scans were obtained for 185 patients. The L3 vertebra was identified manually and machine learning software was used to assist skeletal muscle segmentation. Crosssectional area of skeletal muscle was obtained and normalised to patients’ height. This provided skeletal muscle index (SMI). Sarcopenia was defined using sexspecific international consensus SMI definitions of <39 cm²/m² in women and <55 cm²/m² in men. Associations between pre-treatment sarcopenia and OS and PFS were analysed using univariate and multivariate Cox proportional hazards models and Kaplan-Meier (KM) curves. Results Of 244 patients, 114 (46.7%) were sarcopenic, 71 (29.1%) were non-sarcopenic and 59 (24.2%) had unknown SMI as CT scans were not available. Sarcopenic patients tended to be male (85.1% vs 61.1% in non-sarcopenic patients). No significant differences were observed with respect to age, T stage, smoker status, presence of carcinoma in situ, albumin, haemoglobin, adult comorbidity evaluation-27, World Health Organisation Performance Status (WHO PS), hydronephrosis, neutrophil count, lymphocyte count, tumour stage and provision of neoadjuvant chemotherapy. Median OS and PFS were 40 (interquartile range [IQR] 23.8 – 62) and 32 (IQR 14 - 54.3) months respectively (see figure 1). Univariate analysis showed no association between sarcopenia and OS or PFS. On multivariate analysis, WHO PS, hydronephrosis and neutrophil count were associated with worse OS and PFS. Conclusion Sarcopenia is not associated with worse OS or PFS in bladder cancer patients treated with concurrent chemoradiotherapy.
    Citation
    Corden M, Chin S, Cree A, Hoskin P, McWilliam A, Satiti AD, et al. PO-1216: Can sarcopenia predict outcomes in bladder cancer patients treated with chemoradiotherapy? Radiotherapy and Oncology . 2020 Nov;152:S640.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/624162
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.